The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUC.L Regulatory News (NUC)

  • There is currently no data for NUC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Platform Agreement

19 Nov 2018 07:00

RNS Number : 6931H
Nucleus Financial Group PLC
19 November 2018
 

19 November 2018

Nucleus Financial Group Plc

("Nucleus" or the "Company")

Unbundling of outsourced technology and BPO services through new platform agreement

 

In line with the technology strategy set out in the Company's admission document, Nucleus (AIM: NUC), a leading independent wrap platform provider, announces that it has executed a long-term agreement with Bravura Solutions (UK) Ltd ("Bravura") to provide direct access to its Sonata application, the core system underpinning the Nucleus wrap platform. This new agreement, coupled with recent recruitment in key areas of its technology team, will enhance the Company's control over the platform technology and enable Nucleus to accelerate the rate of product development for the benefit of its users. The board believes this will assist the Company in driving future inflows and AUA growth.

Access to the Sonata application has, to date, been provided through an outsourcing agreement with OpenWealth (a trading name of Genpact WM Limited). As part of an amended agreement, OpenWealth will continue to provide Nucleus with BPO services including account servicing and administration.

The new agreement with Bravura will see Nucleus have a direct contractual relationship with Bravura for the Bravura Sonata application and associated change management services. A new dedicated team has been set up internally with additional resources to ensure a seamless transition. The aggregate cost structure of the agreements with Bravura and OpenWealth is consistent with Company's previous arrangements, is expected to be broadly cost neutral to the business and will strengthen the technology foundations.

Andrew Smith, chief technology officer of Nucleus, said: "We are excited to be working directly with Bravura after working with them indirectly for such a long period. This new arrangement is of vital importance to the ongoing process and pace of development at Nucleus as we prepare the business for significant scale in our second decade in business. By working with Bravura directly, we believe we will be able to better deliver regular platform updates that will substantially improve propositional and regulatory change for the benefit of our users and their clients."

David Ferguson, founder and chief executive of Nucleus, said: "We expect the long-planned unbundling of the current outsourced technology and BPO services and direct relationship with Bravura to materially strengthen our technology foundations and create optionality in our future organisational design and ultimately support our plans to deliver further margin expansion. Nucleus has grown strongly in the last few years and we expect this development to allow us to accelerate the pace of change to allow us to build on the assured progress of recent years."

Tony Klim, group CEO of Bravura, said: "We have been working with Nucleus since it launched and we are pleased to see the relationship develop to this point. Sonata enables Nucleus to connect and engage with their clients anytime, anywhere, using their choice of device. We hope that by working directly with us, Nucleus will be able to develop their technology further to benefit its users positively."

< Ends >

For further information please contact:

Nucleus

David Ferguson, CEO Tel: +44 (0)13 1226 9800

Stuart Geard, Chief Financial Officer 

Andrew Smith, Chief Technology Officer

 

Shore Capital (Nominated Adviser and Broker)

Hugh Morgan Tel: +44 (0)20 7408 4090

Edward Mansfield

Daniel Bush 

 

Camarco (Media enquiries)

Jennifer Renwick Tel: +44 (0)20 3757 4994

Jake Thomas

 

Notes to Editors

About Nucleus

Nucleus is a wrap platform founded in 2006 by advisers committed to altering the balance of power in the industry by putting the client centre stage. It provides independent wrap platform services to over 1,390 active adviser users across more than 800 financial adviser firms as at 30 September 2018. It is responsible for assets under administration ("AUA") of £14.7bn on behalf of more than 92,000 customers.

The multi award-winning platform offers a range of custody, trading, payment, reporting, fee-handling, research and integration services across a variety of tax wrappers and more than 6,500 asset choices including cash, OEICs, unit trusts, offshore funds, structured products and listed securities, including ETFs and investment trusts.

The Platform currently facilitates over 1.1 million client account transactions on average per month.

Nucleus has won CoreData's 'Best medium sized platform' for 2018 (and the last seven years), the Schroders 'Platform of the year' award for 2018 (and the last three years) and recently won 'Best platform' and award for 'Platform innovation' at the 2018 Money Marketing Awards.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRFFMEFAFASEFF
Date   Source Headline
3rd Dec 202011:07 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
2nd Dec 20205:35 pmRNSStatement re Nucleus Financial Group plc
2nd Dec 202012:07 pmRNSStatement regarding a Possible Offer
17th Nov 20207:00 amRNSDirector/PDMR Shareholding
2nd Nov 20207:00 amRNSAcquisition of certain assets of OpenWealth
23rd Oct 20207:00 amRNSQ3 2020 AUA update
13th Oct 20201:35 pmRNSDirector/PDMR Shareholding
28th Sep 202012:18 pmRNSDirector/PDMR Shareholding
15th Sep 20209:26 amRNSDirector/PDMR Shareholding
8th Sep 20207:00 amRNSInterim Results
14th Aug 20207:00 amRNSNotice of Interim Results
14th Aug 20207:00 amRNSDirector/PDMR Shareholding
24th Jul 20207:00 amRNSQ2 2020 AUA update
14th Jul 20207:00 amRNSDirector/PDMR Shareholding
16th Jun 202012:10 pmRNSDirector/PDMR Shareholding
20th May 20203:44 pmRNSGrant of long term incentive awards
20th May 20201:14 pmRNSResult of AGM
14th May 20207:00 amRNSDirector/PDMR Shareholding
15th Apr 20204:13 pmRNSNotice of AGM
15th Apr 20202:15 pmRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSFinal Results
23rd Mar 20204:40 pmRNSCovid-19 and trading update
17th Mar 20202:28 pmRNSDirector/PDMR Shareholding
26th Feb 20207:00 amRNSNon-Executive Director Changes
13th Feb 20204:15 pmRNSDirector/PDMR Shareholding
31st Jan 20207:00 amRNSQ4 2019 AUA update
29th Jan 20202:20 pmRNSHolding(s) in Company
15th Jan 20203:43 pmRNSDirector/PDMR Shareholding
16th Dec 20192:37 pmRNSDirector/PDMR Shareholding
22nd Nov 20193:50 pmRNSDirector/PDMR Shareholding
14th Nov 201912:00 pmRNSDirector/PDMR Shareholding
25th Oct 20197:00 amRNSQ3 2019 AUA update
18th Oct 20195:38 pmRNSDirector/PDMR Shareholding
16th Oct 201911:15 amRNSDirector/PDMR Shareholding
17th Sep 20194:45 pmRNSDirector/PDMR Shareholding
10th Sep 20197:00 amRNSInterim Results
16th Aug 20197:00 amRNSNotice of Results
15th Aug 20193:58 pmRNSDirector/PDMR Shareholding
26th Jul 20197:00 amRNSQ2 2019 AUA update
16th Jul 20199:00 amRNSDirector/PDMR Shareholding
14th Jun 20194:48 pmRNSDirector/PDMR Shareholding
23rd May 201911:35 amRNSResult of AGM
17th May 20197:00 amRNSDirector/PDMR Shareholding
29th Apr 20197:00 amRNSQ1 2019 AUA update
16th Apr 20191:58 pmRNSDirector/PDMR Shareholding
11th Apr 20192:24 pmRNSPosting of Annual Report and Notice of AGM
4th Apr 20198:20 amRNSHolding(s) in Company
3rd Apr 20191:50 pmRNSGrant of long term incentive awards to PDMRs
2nd Apr 20197:00 amRNSPreliminary results
14th Mar 20194:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.